+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wearable Injector Market Research Report by Type (Body Worn Patch Injector and Off Body Worn Patch Injector), Application, End Use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4989995
  • Report
  • April 2022
  • Region: Global
  • 216 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Amgen Inc.
  • Gerresheimer AG
  • Johnson & Johnson
  • Neuma LLC
  • SONCEBOZ SA
  • Valeritas, Inc.
The Global Wearable Injector Market size was estimated at USD 6,358.74 million in 2021, USD 7,057.48 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.16% to reach USD 12,000.44 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Wearable Injector to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Body Worn Patch Injector and Off Body Worn Patch Injector.
  • Based on Application, the market was studied across Autoimmune Disease, Cardiovascular Disease, Diabetes, Infectious Disease, and Oncology.
  • Based on End Use, the market was studied across Clinic, Home Care Setting, Hospital, Online Pharmacy, Retail Pharmacy, and Specialty Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wearable Injector market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wearable Injector Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wearable Injector Market, including Amgen Inc., BASF SE, Becton, Dickinson and Company, DCA Design International Ltd, E3D Elcam Drug Delivery Devices, Gerresheimer AG, Insulet Corporation, Johnson & Johnson, Medtronic PLC, Neuma LLC, SCHOTT AG, SONCEBOZ SA, Stevanato Group S.p.A., Valeritas, Inc., West Pharmaceutical Services, Inc., and Ypsomed AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Wearable Injector Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wearable Injector Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Injector Market?
4. What is the competitive strategic window for opportunities in the Global Wearable Injector Market?
5. What are the technology trends and regulatory frameworks in the Global Wearable Injector Market?
6. What is the market share of the leading vendors in the Global Wearable Injector Market?
7. What modes and strategic moves are considered suitable for entering the Global Wearable Injector Market?
Frequently Asked Questions about the Global Wearable Injector Market

What is the estimated value of the Global Wearable Injector Market?

The Global Wearable Injector Market was estimated to be valued at $6358.7 Million in 2021.

What is the growth rate of the Global Wearable Injector Market?

The growth rate of the Global Wearable Injector Market is 11.1%, with an estimated value of $12000.4 Million by 2027.

What is the forecasted size of the Global Wearable Injector Market?

The Global Wearable Injector Market is estimated to be worth $12000.4 Million by 2027.

Who are the key companies in the Global Wearable Injector Market?

Key companies in the Global Wearable Injector Market include Amgen Inc., BASF SE, Becton, Dickinson and Company, DCA Design International Ltd, E3D Elcam Drug Delivery Devices, Gerresheimer AG, Insulet Corporation, Johnson & Johnson and Neuma LLC.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Gerresheimer AG
  • Johnson & Johnson
  • Neuma LLC
  • SONCEBOZ SA
  • Valeritas, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases and high demand for advanced drug delivery device
5.1.1.2. Rising demand for minimal invasive treatments
5.1.1.3. Need for subcutaneous and continuous drug delivery
5.1.2. Restraints
5.1.2.1. Low adoption in emerging economies
5.1.3. Opportunities
5.1.3.1. Increasing demand for biologics and mAbs
5.1.3.2. Advancement in injector technology
5.1.4. Challenges
5.1.4.1. Preference for alternative drug delivery modes
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Wearable Injector Market, by Type
6.1. Introduction
6.2. Body Worn Patch Injector
6.3. Off Body Worn Patch Injector
7. Wearable Injector Market, by Application
7.1. Introduction
7.2. Autoimmune Disease
7.3. Cardiovascular Disease
7.4. Diabetes
7.5. Infectious Disease
7.6. Oncology
8. Wearable Injector Market, by End Use
8.1. Introduction
8.2. Clinic
8.3. Home Care Setting
8.4. Hospital
8.5. Online Pharmacy
8.6. Retail Pharmacy
8.7. Specialty Clinics
9. Americas Wearable Injector Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Wearable Injector Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Wearable Injector Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Amgen Inc.
13.2. BASF SE
13.3. Becton, Dickinson and Company
13.4. DCA Design International Ltd
13.5. E3D Elcam Drug Delivery Devices
13.6. Gerresheimer AG
13.7. Insulet Corporation
13.8. Johnson & Johnson
13.9. Medtronic PLC
13.10. Neuma LLC
13.11. SCHOTT AG
13.12. SONCEBOZ SA
13.13. Stevanato Group S.p.A.
13.14. Valeritas, Inc.
13.15. West Pharmaceutical Services, Inc.
13.16. Ypsomed AG
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL WEARABLE INJECTOR MARKET: DYNAMICS
FIGURE 2. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 10. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2027
FIGURE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2021 VS 2027 (%)
FIGURE 23. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2027
FIGURE 25. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. ARGENTINA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. BRAZIL WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. CANADA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. MEXICO WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. CHINA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. INDIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. INDONESIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. JAPAN WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. MALAYSIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. SINGAPORE WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. TAIWAN WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. THAILAND WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. FRANCE WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. GERMANY WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. ITALY WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. QATAR WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. RUSSIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. SPAIN WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. GLOBAL WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL WEARABLE INJECTOR MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL WEARABLE INJECTOR MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL WEARABLE INJECTOR MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. ARGENTINA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. BRAZIL WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. CANADA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. MEXICO WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. CHINA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. INDIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. INDONESIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. JAPAN WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. MALAYSIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. SINGAPORE WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. TAIWAN WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. THAILAND WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. FRANCE WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. GERMANY WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. ITALY WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. QATAR WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. RUSSIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. SPAIN WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. GLOBAL WEARABLE INJECTOR MARKET: SCORES
TABLE 102. GLOBAL WEARABLE INJECTOR MARKET: BUSINESS STRATEGY
TABLE 103. GLOBAL WEARABLE INJECTOR MARKET: PRODUCT SATISFACTION
TABLE 104. GLOBAL WEARABLE INJECTOR MARKET: RANKING
TABLE 105. GLOBAL WEARABLE INJECTOR MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 106. GLOBAL WEARABLE INJECTOR MARKET: MERGER & ACQUISITION
TABLE 107. GLOBAL WEARABLE INJECTOR MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 108. GLOBAL WEARABLE INJECTOR MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 109. GLOBAL WEARABLE INJECTOR MARKET: INVESTMENT & FUNDING
TABLE 110. GLOBAL WEARABLE INJECTOR MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 111. GLOBAL WEARABLE INJECTOR MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Amgen Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • DCA Design International Ltd
  • E3D Elcam Drug Delivery Devices
  • Gerresheimer AG
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Neuma LLC
  • SCHOTT AG
  • SONCEBOZ SA
  • Stevanato Group S.p.A.
  • Valeritas, Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
Note: Product cover images may vary from those shown

Loading
LOADING...